進階篩選

Technical category
技術研發單位
  • 共有:筆資料
  • 顯示:
  • 筆商品
    • First-in-class anti-diabetic drug, PS1

      Precision Health Ecosystem FutureTech First-in-class anti-diabetic drug, PS1

      Diabetes is now still an incurable disease. Beta cell failure is one of common causes. No drugs for this failure have been developed. This invention is to developapply PS1 to treatreverse diabetes. PS1 is a first-in-class small-molecule drug, which targets beta cells by improving their survivalfunction. As a result, PS1 can treatreverse diabetes. The anti-diabetic mechanism of
    • Potential of Ambient Mass Spectrometry for Rapid DrugsToxin Identification

      National Synchrotron Radiation Research Center FutureTech Potential of Ambient Mass Spectrometry for Rapid DrugsToxin Identification

      Through combining the cutting-edge technology of TD-ESI/MS to its comprehensive database library of toxicants, a fast-track toxicant analytical platforma set of standard operating procedures are developed that enables the emergency physicians to access correct toxicological information within a short turnaround timerescue the poisoned patients based on accurate laboratory data.
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。